Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026)

Maxcyte (MXCT) has reported Other Non-Current Assets for 7 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets fell 63.17% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 63.17% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, up 61.03% from the prior year.
• Other Non-Current Assets was $1.0 million for Q2 2026 at Maxcyte, down from $2.6 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.8 million in Q2 2025 and troughed at $295000.0 in Q1 2024.
• A 5-year average of $1.3 million and a median of $1.0 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets soared 547.8% in 2025 and slumped 63.17% in 2026, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $809000.0 in 2022, then slumped by 52.04% to $388000.0 in 2023, then soared by 294.85% to $1.5 million in 2024, then soared by 61.03% to $2.5 million in 2025, then sank by 58.25% to $1.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.0 million (Q2 2026), $2.6 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.